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Abstract
Background: The transcription factor Pax6 is expressed by many cell types in the developing eye. Eyes do not form in
homozygous loss-of-function mouse mutants (Pax6Sey/Sey) and are abnormally small in Pax6Sey/+ mutants. Eyes are also
abnormally small in PAX77 mice expressing multiple copies of human PAX6 in addition to endogenous Pax6; protein
sequences are identical in the two species. The developmental events that lead to microphthalmia in PAX77 mice are not
well-characterised, so it is not clear whether over- and under-expression of Pax6/PAX6 cause microphthalmia through
similar mechanisms. Here, we examined the consequences of over-expression for the eye and its axonal connections.
Results: Eyes form in PAX77+/+ embryos but subsequently degenerate. At E12.5, we found no abnormalities in ocular
morphology, retinal cell cycle parameters and the incidence of retinal cell death. From E14.5 on, we observed
malformations of the optic disc. From E16.5 into postnatal life there is progressively more severe retinal dysplasia and
microphthalmia. Analyses of patterns of gene expression indicated that PAX77+/+ retinae produce a normal range of cell
types, including retinal ganglion cells (RGCs). At E14.5 and E16.5, quantitative RT-PCR with probes for a range of
molecules associated with retinal development showed only one significant change: a slight reduction in levels of mRNA
encoding the secreted morphogen Shh at E16.5. At E16.5, tract-tracing with carbocyanine dyes in PAX77+/+ embryos
revealed errors in intraretinal navigation by RGC axons, a decrease in the number of RGC axons reaching the thalamus
and an increase in the proportion of ipsilateral projections among those RGC axons that do reach the thalamus. A survey
of embryos with different Pax6/PAX6 gene dosage (Pax6Sey/+, Pax6+/+, PAX77+ and PAX77+/+) showed that (1) the total
number of RGC axons projected by the retina and (2) the proportions that are sorted into the ipsilateral and
contralateral optic tracts at the optic chiasm vary differently with gene dosage. Increasing dosage increases the
proportion projecting ipsilaterally regardless of the size of the total projection.
Conclusion: Pax6 overexpression does not obviously impair the initial formation of the eye and its major cell-types but
prevents normal development of the retina from about E14.5, leading eventually to severe retinal degeneration in
postnatal life. This sequence is different to that underlying microphthalmia in Pax6+/- heterozygotes, which is due primarily
to defects in the initial stages of lens formation. Before the onset of severe retinal dysplasia, Pax6 overexpression causes
defects of retinal axons, preventing their normal growth and navigation through the optic chiasm.
Published: 28 May 2008
BMC Developmental Biology 2008, 8:59 doi:10.1186/1471-213X-8-59
Received: 11 September 2007
Accepted: 28 May 2008
This article is available from: http://www.biomedcentral.com/1471-213X/8/59
© 2008 Manuel et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Developmental Biology 2008, 8:59 http://www.biomedcentral.com/1471-213X/8/59
Page 2 of 21
(page number not for citation purposes)
Background
The transcription factor Pax6 is expressed dynamically
during the early development of the mouse eye in both
the surface ectoderm and the optic vesicle, which integrate
to generate the structures of the eye [1-3]. As morphogen-
esis proceeds, Pax6 is expressed in the lens, retinal pig-
ment epithelium and retina [1-4]. Most studies examining
the functions of Pax6 in eye development have exploited
loss-of-function models. The optic cup fails to form in
embryos completely lacking Pax6 [5]. Examination of
Pax6+/+ ↔ Pax6-/- mouse chimeras has shown that Pax6 is
required cell autonomously in the optic vesicle for main-
tenance of contact with the overlying surface ectoderm, a
necessary event in eye formation, providing a clue that
Pax6 may be involved in defining the adhesive properties
of these cells [6,7]. Heterozygous Pax6+/- embryos show
microphthalmia that is thought to be caused by delayed
development of the lens and anterior eye structures [8].
Data from Pax6+/- ↔ Pax6+/- chimeras has demonstrated
that heterozygous cells have early cell autonomous defi-
ciencies at lens placode formation and after closure of the
lens pit [9]. Studies using Cre-lox technology to selectively
disrupt Pax6 in discrete parts of the developing eye have
shown that removing Pax6 from the developing surface
ectoderm produces an eye lacking a lens but possessing a
retina with retinal ganglion cells (RGCs) able to project
axons [10]. Removing Pax6 function after the retina forms
results in a retina comprising mainly amacrine cells at the
expense of other retinal cell types including RGCs [3].
Gain-of-function models are also useful for assessing gene
function, particularly where, as in the case of Pax6,
absence of function leads to complete abolition of a struc-
ture or cell type. In some parts of the developing brain
Pax6 has functions in axon guidance as well as in tissue
morphogenesis and regulates genes implicated in growth
cone navigation [11]. Since absence of Pax6 results in
absence of RGCs, it is unclear whether Pax6 has a role in
the navigation of retinal axons. Its expression by project-
ing RGCs [4] indicates that it is poised to fulfil this func-
tion. Here, we investigated the formation of the eye, retina
and retinal projections in mice that over-express Pax6 and
we complemented our analysis of retinal projections in
the gain-of-function model by studying retinal projec-
tions in Pax6+/- embryos.
Controlled overexpression of Pax6 in its normal domains
of expression has been achieved by the generation of a
YAC transgenic mouse expressing several copies of the
human PAX6 gene, which generates protein identical to
mouse Pax6, under the control of all its regulatory ele-
ments [12]. PAX77 hemizygous mice carry 5 to 7 copies of
the human PAX6 gene, all integrated at the same locus,
and are designated PAX77+  [12]. PAX77 homozygous
transgenic mice are designated PAX77+/+. Schedl et al. [12]
showed that over-expression of PAX6 causes microphthal-
mia in adults but did not study the development of this
defect. Here we show that the eye initially forms appar-
ently normally but that retinal defects and microphthal-
mia emerge and become increasingly severe during
subsequent embryogenesis and postnatal life. We also
show that Pax6 overexpression causes defects in RGC
axon growth and guidance through the optic chiasm,
where RGC axons are sorted into those that project ipsilat-
erally and those that project contralaterally. Our results
indicate that although both over- and under-expression of
Pax6 cause microphthalmia, the underlying mechanisms
are different.
Results
Pax6/PAX6 protein and mRNA levels are increased in the 
eye of PAX77 embryos
We compared Pax6/PAX6 (mouse + human) expression in
wild-type and PAX77+/+ eyes by immunohistochemistry
on sections of E12.5 and E14.5 embryos. The pattern of
expression of Pax6/PAX6 in the eye of PAX77+/+ embryos
reproduces that in the wild-types (Fig 1A, B). As expected,
the levels of Pax6/PAX6 in PAX77+/+ eyes appear increased
compared to those in wild-types (Fig 1A, B). We also
measured the levels of specifically mouse Pax6 mRNA and
both mouse and human Pax6/PAX6 mRNA in the retinae
of E14.5 wild-type and PAX77+/+ embryos by quantitative
RT-PCR (qRT-PCR). We found that the total levels of Pax6/
PAX6 mRNA are increased by about 2.5 fold in PAX77+/+
compared to wild-type retinae (Fig 1C). This increase is
lower than might be expected from the increase in gene
copy number (5–7 fold), suggesting that Pax6 negatively
autoregulates in the retina, as it does in the brain [13]. In
agreement with this, we found that the levels of endog-
enous mouse Pax6 mRNA are decreased in PAX77+/+ reti-
nae compared to wild-type retinae (Fig 1C), indicating
that overproduction of PAX6 from the YAC transgenes
represses production from the endogenous Pax6 loci. For
convenience, we refer elsewhere in this paper to the over-
expression in PAX77 mice as being an overproduction of
Pax6, rather than Pax6/PAX6, since the human and mouse
protein sequences are identical.
Eye development until E12.5 is similar in wild-type and 
Pax6-overexpressing embryos
At early stages of embryogenesis, up to E12.5, the eyes of
PAX77+/+ embryos appear similar to those of the wild-
types in both size and morphology (Fig 2A, G). They do
not show the lens defects reported in Pax6+/- embryos at
this age [8,9]. We tested for more subtle defects of cell pro-
liferation and death at this age but found no evidence for
either. We used the technique of sequential labeling of
cells in S-phase with BrdU and IdU [14,15] to estimate the
cell-cycle length (TC) and the length of the S-phase (TS)
of retinal progenitors (Fig 3). We did not find any signifi-BMC Developmental Biology 2008, 8:59 http://www.biomedcentral.com/1471-213X/8/59
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Pax6 is overexpressed in the eye of PAX77+/+ embryos Figure 1
Pax6 is overexpressed in the eye of PAX77+/+ embryos. Horizontal sections through the eye of wild-type and PAX77+/+ 
embryos at (A) E12.5 and (B) E14.5, showing the expression of Pax6/PAX6. (C) Levels of endogenous Pax6 mRNA and total 
Pax6/PAX6 mRNA in the retina of E14.5 PAX77+/+ embryos, relative to wild-types, determined by real time quantitative RT-
PCR and normalised against GAPDH mRNA levels (n = 3 in each case).Pax6 mRNA levels are significantly decreased in the ret-
inae of PAX77+/+ embryos compared to those of wild-types (Student's t-test, p = 0.014) while Pax6/PAX6 mRNA levels are sig-
nificantly increased (Student's t-test, p < 0.001). Scale bars: A, 200 µm; B, 500 µm.
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Overexpression of Pax6 in the eye results in microphthalmia and retinal dysplasia Figure 2
Overexpression of Pax6 in the eye results in microphthalmia and retinal dysplasia. Horizontal sections through the 
eyes of wild-type and PAX77+/+ eyes stained with cresyl violet. (A, G) E12.5, (B,H) E14.5, (C) E16.5, (D,I,J) E18.5, (E,K) P4, (F,L) 
P6. (A-F) As the eye develops the retina of PAX77+/+ mice becomes progressively smaller than in wild-type mice. (B,C,D) A 
retrolental nodule (arrow) is present in the mutant eye from E14.5. (E,F) After birth, the vitreous chamber (*) has almost com-
pletely disappeared in the PAX77+/+ eye and parts of the retina are in close contact with the lens. (H) Cells continuous with the 
pigmented epithelium (arrowhead) and the retina extend ectopically along the mutant optic stalk (arrow). (I) At E18.5, in the 
PAX77+/+ eye the iris (arrow) is folded and in direct contact with the lens epithelium. (J) At E18.5 the retina is comprised of 2 
well defined neuroblastic layers in mutant as in wild-type embryos. (K) At P4 the outer layer of the PAX77+/+ retina starts to 
form rosettes (arrows). (L) At P6 PAX77+/+ eyes display variable levels of rosetting of the outer nuclear layer. The PAX77+/+ eye 
shown here displays severe rosetting. L, lens; OS, optic stalk; R, retina; OL, outer layer; IL, inner layer. Scale bars : A-F, 500 
µm; G-L, 100 µm.
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cant difference in the estimated TS (Fig 3B) or TC (Fig 3C)
in the proximal and distal retina of E12.5 PAX77+/+
embryos compared to wild-types (P > 0.05, Student's t
test, n = 3 wild-type and 3 PAX77+/+ embryos). We per-
formed an analysis of cell death in the retina by examin-
ing the pattern of dying cells clearly visible on thin plastic
sections as pyknotic nuclei. Pyknosis is the most charac-
teristic feature of apoptosis and counting pyknotic nuclei
is a standard way of looking at cell death in the retina [16-
30]. In a previous study we counted apoptotic cells in the
brain by counting pyknotic nuclei as well as by counting
Terminal Uridine Deoxynucleotidyl Transferase dUTP
Nick End Labeling (TUNEL) positive cells and found that
both techniques gave the same result [31].We did not
observe any obvious increase in the number of pyknotic
figures per 2 µm section through the eye of E12.5 PAX77+/
+ embryos compared to wild-types. In sections from eyes
of both genotypes there were between 0 and 2 pyknotic
figures per section. Thus, there does not appear to be a
dysregulation of progenitor proliferation and death at
early stages of retinogenesis in PAX77+/+ embryos.
Overexpression of Pax6 results in optic disc 
malformations, progressive retinal dysplasia and 
microphthalmia from E14.5
As development progresses PAX77+/+ retinae become pro-
gressively smaller than normal while the size and appear-
ance of their lenses appears relatively less affected (Fig 2B–
F). As a consequence, from postnatal day (P) 2 their vitre-
ous chambers have almost completely disappeared and
parts of their retinae and lenses are in direct contact (Fig
2E, F).
Morphological defects are first detected at E14.5 with the
development of persistent hyperplastic primary vitreous
(PHPV), a condition that arises when the hyaloid canal
does not retract appropriately towards the optic nerve
head leaving a tissue nodule (arrow in Fig 2B–D) [32],
and malformations of the optic disc (Fig 2B, H). At this
stage in the wild-type, the pigmented epithelium (arrow-
head in Fig. 2H) and the retinal neuroepithelium stop
sharply at the junction of the optic cup and optic stalk,
whereas in the mutant, cells continuous with those of pig-
mented epithelium and neural retinal cells extend along
the optic stalk (arrow in Fig 2H). Taken together, these
results indicate that failure of the optic nerve head to
develop normally is an early feature in PAX77+/+ embryos.
Defects of RGC axons at around this time are analysed in
greater detail below.
By E18.5 the retinae of PAX77+/+ eyes have become signif-
icantly smaller than those of the wild-type eyes (Fig 2D)
and the iris appears folded and pushed against the lens
epithelium (arrow in Fig 2I). At E18.5, the wild-type retina
comprises two well-defined layers. The inner layer is the
Pax6 overexpression does not significantly affect retinal pro- genitor proliferation at E125 (A) Horizontal section of the  eye of an E12.5 wild-type embryo labeled with anti-BrdU  (red), anti-IdU (green) and counterstained with TOPRO3  (blue) Figure 3
Pax6 overexpression does not significantly affect reti-
nal progenitor proliferation at E12.5 (A) Horizontal 
section of the eye of an E12.5 wild-type embryo 
labeled with anti-BrdU (red), anti-IdU (green) and 
counterstained with TOPRO3 (blue). Cell counts were 
made in 100 µm wide sampling boxes in the proximal (p) and 
distal (d) retina. (B) Estimated S-phase length (TS) and (C) 
estimated cell cycle length (TC) in the proximal and distal 
retina of wild-type and PAX77+/+ E12.5 embryos. No signifi-
cant differences were detected between the mutants and the 
wild-types (n = 3 of each; Student's t-test; p > 0.05). Scale 
bar: 100 µm.
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differentiated RGC layer and the outer layer is the region
of the retina that is still primarily neuroblastic. While both
layers are present in the mutant retina, the RGC layer
appears to be less structured than in the wild-type retina
(Fig. 2J). Four days after birth, when normal neuronal
production is declining rapidly and the retina is initiating
the differentiation of the inner and outer nuclear layers,
rosette-like structures are starting to form in the outer
layer of the retina of PAX77+/+ mice (Fig 2E, K). In addi-
tion, the peripheral retina is folded back towards what
remains of the vitreous chamber and retinal folds appear
more centrally (Fig 2E). At P6, PAX77+/+ retinae display
degrees of rosetting that vary between eyes and also
between different regions of the same eye. Figures 2F and
2L show a PAX77+/+ eye at P6 with very severe rosetting. In
all P14 PAX77+/+ eyes examined the entire outer nuclear
layer consisted of dysplastic rosettes (Fig 4J) and the retina
displayed extensive gliosis (shown by glial fibrillary acidic
protein [GFAP] staining in Fig 4J).
The abnormality of the optic disc observed in the mutant
embryos from E14.5 is similar to that previously
described in mice heterozygous for the Kidney and retinal
defects (krd) deletion, which display haploinsufficiency
of the transcription factor Pax2 [33]. We could not, how-
ever, detect by immunofluorescence any obvious differ-
ence in the pattern or the level of expression of Pax2 in the
eyes of PAX77+/+ embryos compared to wild-types (Fig 5).
Analysis of patterns of gene expression in the retinae of 
PAX77+/+ and wild-type mice
In the retina of wild-types aged E18.5, proliferative cells
are found in the outer layer while the inner layer contains
the recently differentiated RGCs. We analyzed the organi-
zation of the retina at E18.5 using Brn3a (Fig 4A) as a
marker of RGCs [34,35] and BrdU to label proliferative
cells in S-phase (Fig 4B). There are no obvious differences
in the positions and densities of cells labelled with BrdU
or Brn3a between PAX77+/+ and wild-type retina (Fig 4A,
B). A further quantitative analysis of Brn3a labelling in
wild-type and mutant embryos, presented below in the
context of RGC axonal development, supported these
findings. Thus, at E18.5, although the PAX77+/+ retina is
smaller than the wild-type retina, its organization appears
to be normal.
We analyzed the expression of a broader range of markers
in the postnatal retina, at P6. The RGCs, which express
Pax6, Islet1 and Brn3a [3,36], are present in the mutant
retina but they are not as regularly aligned as in the wild-
type retina (Fig 4C, D and arrowheads in Fig 4I). Pax6,
Islet1 and Syntaxin are expressed by amacrine cells [3,36]
(Fig 4C, D, F; arrowheads), Chx10 is a marker of bipolar
and retinal progenitor cells [37] (Fig 4E; arrows) and Pax6
and R-cadherin are expressed by horizontal cells [3,36,38]
(Fig 4C, G; arrows). Analysis of the expression of these
markers in PAX77+/+ retina provided evidence that all the
major cell types of the inner nuclear layer are produced in
the mutant, but their appearances and distributions are
not normal at P6. Cells expressing markers associated
with cells from the inner nuclear layer accumulate at the
outer surface of the retina (Fig 4C, D, F; stars); their
appearance suggests that they might have migrated
through the outer nuclear layer. In addition, there seem to
be fewer horizontal cells in the PAX77+/+ retina than in the
wild-type retina and they are not as regularly spaced (Fig
4C, G; arrows). In the wild-type retina, R-cadherin is
strongly expressed in the outer plexiform layer, which
contains the horizontal cells' dendrites (Fig 4G; arrow-
heads). The expression of R-cadherin in the outer plexi-
form layer of the mutant retina is much weaker and does
not appear as a continuous line as in the wild-type (Fig
4G). This suggests that the horizontal cells in the mutant
retina do not form normal dendritic connections with
cells in the outer nuclear layer. In the wild-type retina, the
outer limiting membrane is strongly stained by antibodies
against N-cadherin [38,39] (Fig 4H; arrow). The outer
limiting membrane in the PAX77+/+ eye is not as clearly
defined as in the wild-type and it appears discontinuous
(Fig 4H; arrow). Overall, these results indicate that the
major cell types of the normal retina are produced in the
mutants but they are disorganized at P6.
We used real time quantitative RT-PCR to analyze the
mRNA levels of several genes which are implicated in ret-
ina formation and RGC axon navigation and some of
which are known targets of regulation by Pax6. We com-
pared the mRNA levels of our candidates in the retinae of
wild-type and PAX77+/+  embryos at E14.5 and E16.5,
stages at which retinal dysmorphology first emerges in the
mutants (Table 1). Shh, which is expressed specifically by
the RGCs [40,41], is implicated in retinal lamination and
RGC axon guidance [40,41]. We found a small, significant
decrease in the levels of Shh mRNA in the PAX77+/+ reti-
nae compared to the wild-types at E16.5 (Table 1). We
also analyzed the expression of the adhesion molecules
Ncam, R-cadherin and L1 which are implicated in axon
growth and guidance and are transcriptional targets of
Pax6 [11,42-45]. L1, in particular, is essential for topo-
graphic mapping of retinal axons [43]. We did not detect
any difference in expression of these genes in the PAX77+/
+ retina compared to the wild-type. The homeodomain
transcription factor Six3 is an important regulator of reti-
nal development and may regulate retinal progenitor pro-
liferation and cell fate specification [46-48]. There is
evidence that the expression of Six3 is regulated by Pax6
[49]. The bHLH transcription factor Ngn2 has been impli-
cated in the regulation of the specification of RGCs [50]
and is a transcriptional target of Pax6 in the telencephalon
and spinal chord [51,52]. The expression of Six3 andBMC Developmental Biology 2008, 8:59 http://www.biomedcentral.com/1471-213X/8/59
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The different retinal cell types are produced normally in the PAX77+/+ eye Figure 4
The different retinal cell types are produced normally in the PAX77+/+ eye. Horizontal sections through wild-type 
and PAX77+/+ eyes. (A) Expression of the RGC marker Brn3a at E18.5. (B) BrdU labelling (brown) of retinal progenitors in S-
phase in E18.5 eyes. Sections are counterstained with cresyl violet. Expression of (C, J) Pax6 (green) and GFAP (red), (D) 
Islet1, (E) Chx10, (F) Syntaxin, (G) R-cadherin, (H) N-cadherin and (I) Brn3a in the retinae of wild-type and PAX77+/+ pups at P6 
(C to I) and P14 (J). (C,F) Sections are counterstained with TOPRO3. Arrowheads in C,D,F: amacrine cells; arrows in C,G: 
horizontal cells; arrows in E: bipolar and progenitor cells; arrowhead in G: outer plexiform layer; arrow in H: outer limiting 
membrane; stars in C,D,F: ectopic retinal cells; arrowheads in I: RGCs. OL, outer layer; IL, inner layer; ONL, outer nuclear 
layer; INL inner nuclear layer; RGC, retinal ganglion cells. Scale bars : A, 250 µm; B, 150 µm; E, 300 µm; C,D,F,G,H,I,J, 100 µm.
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Ngn2 was not significantly altered in the PAX77+/+ com-
pared to the wild-type retina.
Overexpression of Pax6 results in intraretinal and 
retinothalamic errors in RGC axon navigation
In order to test the hypothesis that normal levels of Pax6
are important for the proper navigation of RGC axons we
first examined the ability of RGC axons to navigate within
the PAX77+/+ retina. We looked at E16.5 retinae as, by this
age in wild-types, large numbers of RGC axons have
grown to the optic nerve head and any defects in intraret-
inal navigation in mutants would be apparent. In wild-
type embryos, RGC axons grow radially towards the optic
nerve head as revealed by immunostaining RGC axons for
L1 (Fig. 6A, B) or neurofilament (Fig. 6C), or labelling
cohorts of RGC axons by DiI injection into the peripheral
retina (Fig. 6D–F). In contrast, in PAX77+/+ embryos RGC
axons take a more erratic path. L1 (Fig. 6G, H) and neuro-
filament (Fig. 6I) immunostaining showed that, as in the
wild-type, RGC axons form bundles that converge on the
optic nerve head. However, whereas in the wild-type these
bundles run approximately linearly and cover the retinal
surface evenly, in the PAX77+/+ embryo they take a more
serpentine course and are not evenly distributed across the
retinal surface. Focal DiI injections labelling cohorts of
RGC axons (Fig. 6J–L) showed that although many axons
do converge on the optic nerve head their course is erratic.
Despite exhibiting abnormal routing within the retina, a
significant number of RGC axons exit the retina at the
optic nerve head and grow into the optic stalk in PAX77+/
+ embryos. During normal development the optic nerves
Pax2 appears to be expressed normally in the optic stalk of the PAX77+/+ eye Figure 5
Pax2 appears to be expressed normally in the optic stalk of the PAX77+/+ eye. Horizontal sections through the eye of 
(A,B) wild-type and (C,D) PAX77+/+ E12.5 embryos showing the expression of Pax2 in the optic stalk. Sections are counter-
stained with TOPRO3. Scale bars: A,C, 300 µm; B,D, 200 µm.
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converge on the ventral surface of the hypothalamus to
form the optic chiasm. Axons are then sorted into the con-
tralateral or ipsilateral optic tracts and navigate to their
targets in the thalamus and superior colliculus. Immunos-
taining for Pax6 in wild-type (Fig. 7A, B) and PAX77+/+
(Fig. 7D) embryos shows that Pax6 is not expressed at
detectable levels at the optic chiasm at E14.5, the age at
which RGC axons are navigating this region. Horizontal
sections of wild-type (Fig. 7C) and PAX77+/+ (Fig. 7E)
optic chiasm following DiI injection into the retina reveal
that in both cases significant numbers of axons reach the
chiasm and continue into the optic tracts. We noticed that
our injections consistently labelled more axons in the
wild-type than in the PAX77+/+ embryos suggesting that
fewer axons reached this region in the PAX77+/+ embryos.
In order to quantify this we counted the numbers of RGC
cell bodies retrogradely labelled by unilateral DiI injec-
tion into the thalamus at E16.5 (Fig. 7F). These counts
confirmed our initial observation that the PAX77+/+ retina
projects fewer axons to the thalamus: the total number of
back-labelled RGCs in the PAX77+/+ retina was reduced
compared to the wild-type (p < 0.05; Mann-Whitney Rank
Sum Test). Interestingly, however, there was a dispropor-
tionate reduction in the contralateral projection which
was reduced by 90% in the PAX77+/+ embryos (p < 0.05;
Mann-Whitney Rank Sum Test) compared to the ipsilat-
eral projection in which there was no significant decrease
(p > 0.05; Mann-Whitney Rank Sum Test). This is exam-
ined in more detail below.
The number of RGCs in the retina is sensitive to Pax6 gene 
dosage
We studied whether the reduction in the number of RGCs
labelled by DiI from the thalamus in PAX77+/+ mutants
could be accounted for by a reduction in the total number
of RGCs in the mutant retina. In view of the interesting
observation that there was a disproportionate reduction
in the contralateral projection in PAX77+/+ mutants, we
extended the study to include embryos with a range of
Pax6 gene dosage. We counted the total number of RGCs,
marked by expression of Brn3a, in whole E16.5 retinae
from Pax6Sey/+, Pax6+/+, PAX77+, and PAX77+/+ embryos.
This analysis showed that all three types of mutant retina
produced about a third fewer Brn3a-expressing RGCs than
the wild-type (Fig. 8A; this was significant p < 0.05; Mann-
Whitney Rank Sum Test) although there was no signifi-
cant difference between the mutant genotypes. This reduc-
tion in RGC number was accounted for by the reduction
in retinal area in Pax6Sey/+, PAX77+, and PAX77+/+ embryos
as the density of Brn3a-expressing cells in the RGC layer
and the depth of the RGC layer were similar in Pax6Sey/+,
Pax6+/+, PAX77+, and PAX77+/+ embryos (Table 2). There
was no significant difference in the density of Brn3a-
expressing cells between ventro-temporal and dorso-nasal
retina for each genotype (Table 2), indicating that the rel-
atively even distribution of RGCs over the retinal surface
seen in wild-types is maintained in all three types of
mutant.
The reduced number of RGCs at E16.5 resulting from
Pax6 overexpression raises the possibility that the onset of
ganglion cell differentiation may be delayed. We therefore
examined the number and distribution of Brn3a express-
ing cells at the onset of RGC differentiation [34,35] in
E12.5 retinae of Pax6+/+, PAX77+, and PAX77+/+ embryos
(Fig 9). We found no differences in the distribution (Fig
9A–F) or number (Fig 9G) of Brn3a positive cells between
the three genotypes. We conclude that the retinal axon
guidance defects caused by Pax6 overexpression do not
arise from delayed onset of RGC differentiation.
The midline crossing behaviour of RGC axons at the optic 
chiasm is sensitive to Pax6 gene dosage
RGC axons are sorted into the optic tracts at the optic chi-
asm. In wild-type mice about 3% do not cross the midline
and grow into the ipsilateral optic tract. The remaining
97% cross the midline and grow into the contralateral
optic tract. In PAX77+/+ embryos the increased levels of
Pax6 correlate with an increase in the proportion of RGCs
projecting ipsilaterally. In order to investigate the relation-
ship between Pax6 and the ipsilateral projection in more
detail we examined other lines of mice with different
numbers of Pax6/PAX6 gene copies.
Table 1: Relative gene expression in PAX77+/+ and wild-type 
embryonic retinae
ratio PAX77+/+/WT
Shh E14.5 0.997 p = 0.982
E16.5 0.839 p = 0.006 *
Ncam E14.5 1.040 p = 0.488
E16.5 0.933 p = 0.356
Rcad E14.5 0.827 p = 0.351
E16.5 1.044 p = 0.744
Six3 E14.5 0.963 p = 0.667
E16.5 0.937 p = 0.474
L1 E14.5 1.180 p = 0.365
E16.5 1.135 p = 0.239
Ngn2 E14.5 0.878 p = 0.342
E16.5 0.907 p = 0.425
Shh mRNA levels are slightly decreased in the retinae of E16.5 
PAX77+/+ embryos compared to the wild-types. mRNA levels of 
potential targets of Pax6 in the retina of E14.5 or E16.5 PAX77+/+ 
embryos, relative to wild-type, determined by real time quantitative 
RT-PCR and normalised against GAPDH mRNA levels (n = 3 to 6). P 
values were given by Student's t-test.BMC Developmental Biology 2008, 8:59 http://www.biomedcentral.com/1471-213X/8/59
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Alterations to RGC axon trajectories within the PAX77+/+ retina at E16.5 Figure 6
Alterations to RGC axon trajectories within the PAX77+/+ retina at E16.5. (A-F) Wild-type (G-L) PAX77+/+: panels 
show flatmounted retinae in which retinal axons are detected using (A,B,G.H) L1 immunostaining, (C,I) neurofilament immu-
nostaining, or (D-F, J-L) DiI labelling following focal injection of DiI into the peripheral retina. In wild-type embryos retinal 
axons grow directly towards the optic nerve head in the centre of the retina. In PAX77+/+ embryos, although this radial organi-
sation is grossly preserved, the retinal axons take a more erratic route. (B,C) In the wild-type axon bundles are uniformly 
spaced and appear parallel when viewed at high magnification. (D,E) DiI focal injections label cohorts of axons which grow 
straight towards the optic nerve head (demarcated by dotted circle in E,K). In contrast in PAX77+/+ embryos axon bundles are 
less evenly distributed and avoid some parts of the retina altogether (arrows in H,I,K). (F,L) Higher magnification of DiI labelled 
axons in the retina showing individual axons. (F) In the wild-type these run parallel to one another but (L) in the PAX77+/+ ret-
ina they do not. Scale bars: (A,D,E,G,J,K), 100 µm; (B,C,F,H,I,L), 50 µm.
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Alterations to RGC axon numbers and behaviour at the optic chiasm of PAX77+/+ embryos Figure 7
Alterations to RGC axon numbers and behaviour at the optic chiasm of PAX77+/+ embryos. (A,B,D) Pax6 immu-
nostaining of E14.5 coronal section. (A) In the wild-type Pax6 expression is not detectable at the optic chiasm (oc) although it 
is evident in other parts of the brain. Higher magnification of the oc of (B) wild-type and (D) PAX77+/+ embryos show that in 
neither case is Pax6 immunostaining detectable. (C, E) Horizontal sections showing DiI-labelled retinal axons as they traverse 
the chiasm, following injections of label into the retina. In both (C) wild-type and (E) PAX77+/+ embryos, retinal axons reach the 
chiasm along the optic nerve (on) and follow similar trajectories into the optic tract (ot). White dotted lines in (B-E) demarcate 
the midline. (F) Quantification of RGC projections to the thalamus in wild-type and PAX77+/+ embryos at E16.5 obtained by 
injecting DiI into the thalamus (on one side only) and counting RGCs retrogradely labelled by DiI in the ipsilateral and contral-
ateral retinae. Note that PAX77+/+ embryos exhibit a dramatic decrease in the number of contralaterally projecting RGCs 
which is statistically significant (p = 0.008; Mann-Whitney Rank Sum Test). The slight reduction in the number of ipsilaterally 
projecting RGCs is not significant (p = 0.317; Rank Sum Test). * indicates significant difference (p < 0.05; Mann-Whitney Rank 
Sum Test). Number of embryos analysed: Pax6+/+ n = 9; PAX77+/+ n = 4. Scale bars: (A) 500 µm; (B-E) 100 µm.
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Small-eye heterozygote (Pax6Sey/+) embryos have only one
functional copy of Pax6 [5]. Loss of one functional copy
of Pax6 in Pax6Neu/+ embryos produces a hypoplastic optic
nerve [53]. Quantification of RGCs retrogradely labelled
by unilateral DiI injection into the thalamus confirm that
the total projection in Pax6Sey/+ embryos is reduced to 12%
(p < 0.05; Mann-Whitney Rank Sum Test) of that seen in
wild-types (Fig 8B). In contrast to the PAX77+/+ embryos,
however, the reduction affects ipsilateral and contralateral
projections equally and the proportion of RGCs project-
ing ipsilaterally is 3%, not significantly different to the
2.5% in the wild-type (Fig 8C; p > 0.05; Mann-Whitney
Rank Sum Test). Reducing the number of functional Pax6
gene copies reduces the number of RGC axons projected
by the retina to the thalamus but does not affect the pro-
portion that cross the midline at the optic chiasm. Thus,
reduction in the number of RGCs, which occurs in both
Pax6Sey/+  and  PAX77+/+  embryos, is not sufficient to
explain the increased proportion of ipsilateral projections
in PAX77+/+ mutants, which must be regulated separately
by gene dosage.
PAX77+ hemizygotes [12] contain 5 to 7 copies of human
PAX6  in addition to the two endogenous mouse Pax6
genes. The Pax6/PAX6 gene dosage in these embryos is
therefore intermediate between wild-type embryos and
PAX77+/+ embryos [12]. Quantification of RGCs retro-
gradely labelled by unilateral DiI injection into the thala-
mus showed no significant difference in the overall
numbers of RGCs projecting into the brain compared to
wild-types (p > 0.05; Mann-Whitney Rank Sum Test; Fig
8B), even though the total number of Brn3a-expressing
RGCs was less than in wild-types (Fig. 8A). The propor-
tion of RGCs projecting ipsilaterally was about 10%, sig-
nificantly more than the 2.5% seen in wild-types (p <
0.05; Mann-Whitney Rank Sum Test; Fig 8C). As described
above, in PAX77+/+ embryos there is a significant reduc-
tion of the total projection to 10% of its normal size (p <
0.05; Mann-Whitney Rank Sum Test; Figs 7F and 8B) of
which 11% is ipsilateral, a significant increase compared
to the wild type ipsilateral projection (p < 0.05; Mann-
Whitney Rank Sum Test; Fig 8C). The tendency of ipsilat-
erally projecting RGCs to be most concentrated in the ven-
tro-temporal retina, which has been well established in
Pax6+/+  embryos [eg [42,44,49]], was maintained in
Pax6Sey/+, PAX77+, and PAX77+/+ embryos (Table 3) irre-
spective of the changes in the total number or proportion
of ipsilaterally projecting RGCs. These results, summa-
rised in Fig 8D, show that increasing the number of func-
tional PAX6 gene copies increases the proportion of RGC
axons projecting ipsilaterally independently of its effect
on the total numbers of RGCs whose axons reach the tha-
lamus.
Discussion
We analyzed the effects of Pax6 overexpression on the
development of the neural retina and on its ability to
project axons to the brain. Our results indicate that, in the
eye of PAX77+/+ embryos, (1) development proceeds nor-
mally until about E12.5, (2) the first defects, which are of
the optic nerve and the growth and navigation of RGC
axons, emerge at E14.5–E16.5, (3) major retinal cell types
are generated and (4) there is progressive retinal dysplasia
and microphthalmia from E18.5 into postnatal life. The
globe and retina fail to grow and by P4 the vitreous has
almost disappeared leaving the retina in contact with the
lens. Retinal lamination is also affected with the appear-
ance of many rosettes and abnormal horizontal cells. One
clear conclusion from these findings is that while both
over- and under-expression of Pax6 cause microphthal-
mia, the underlying mechanisms are different. Microph-
thalmia in Pax6Sey/+ mice is thought to be caused by
primary defects of the lens and anterior structures occur-
ring at the time of initial eye formation rather than with
later retinal defects [8,9].
Table 2: 
genotype Retina area [µm2 × 106] RGC layer depth [µm] Density of Brn3a expressing cells in RGC layer 
[cells/µm3 × 10-3]
Brn3a expressing cells/
retina × 103
dn vt
Pax6Sey/+ 1.74 ± 0.18 17.6 ± 1.4 7.9 ± 0.1 7.4 ± 0.6 241 ± 40
Pax6+/+ 2.90 ± 0.24 16.4 ± 1.6 8.9 ± 1.1 8.4 ± 0.3 405 ± 41
PAX77+ 1.87 ± 0.24 18.9 ± 3.0 7.5 ± 0.2 7.6 ± 0.2 260 ± 15
PAX77+/+ 1.86 ± 0.20 17.9 ± 3.9 8.3 ± 0.3 8.5 ± 0.2 269 ± 28
Numbers and distributions of Brn3a expressing RGCs in Pax6Sey/+, Pax6+/+, PAX77+, and PAX77+/+ embryos. Note that the reduced number of 
Brn3a-expressing cells in the Pax6Sey/+, PAX77+, and PAX77+/+ embryos compared to Pax6+/+ embryos (see Fig 7 A) appears to correspond to a 
reduction in retinal area [that is having smaller eyes] as opposed to changes in the density or distribution of Brn3a-expressing cells in the retina. All 
values mean ± s.e.m. Sample sizes: Pax6Sey/+ n = 5; Pax6+/+ n = 4; PAX77+ n = 3; PAX77+/+ n = 3. Abbreviations: dn, dorsonasal quadrant; vt, 
ventrotemporal quadrant.BMC Developmental Biology 2008, 8:59 http://www.biomedcentral.com/1471-213X/8/59
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Pax6/PAX6 gene dosage affects both the total number of RGCs, the number of RGC axons projected to the thalamus and the  proportion that project ipsilaterally Figure 8
Pax6/PAX6 gene dosage affects both the total number of RGCs, the number of RGC axons projected to the thalamus and the propor-
tion that project ipsilaterally. (A) Quantification of Brn3a-expressing cells in the retinae of E16.5 Pax6Sey/+, Pax6+/+, PAX77+ and PAX77+/+ embryos. 
Left, a wholemount retina immunostained with Brn3a antibody (green fluorescence). Dotted circle indicates location of optic nerve head. Boxed area 
shows location of one of the 160 µm × 160 µm sampling areas, in this case in ventro-temporal retina, used to calculate density of Brn3a-expressing cells 
(see Methods). The inset is an example of high power image showing individual Brn3a-expressing nuclei. Histogram on right shows the average total 
number of Brn3a-expressing cells in the retina Sample sizes: Pax6Sey/+ n = 5; Pax6+/+ n = 4; PAX77+ n = 3; PAX77+/+ n = 3. (B) Histogram showing the total 
numbers of RGCs per retina retrogradely labelled by unilateral injection of DiI into the dorsal thalamus of E16.5 embryos. Each bar is divided into ipsilat-
eral (black) and contralateral (white) components. (C) Histogram showing the percentage of RGCs projecting ipsilaterally calculated from the data pre-
sented in (B). Sample sizes in B and C: Pax6Sey/+ n = 4; Pax6+/+ n = 9; PAX77+ n = 5; PAX77+/+ n = 4. In A-C, the embryo genotypes are indicated below each 
graph and are arranged in order of increasing Pax6/PAX6 gene dosage. In all histograms error bars are s.e.m.s with * indicating a significant difference from 
Pax6+/+ embryos (p < 0.05 Mann-Whitney Rank Sum test). (E) Cartoon summarising the relationship between Pax6 gene dosage, and the number and loca-
tion of RGCs generated by the retina (ovals), and whether they project ipsilaterally (filled red) contralaterally (filled yellow) or fail to project (unfilled) to 
the thalamus. Scale bar in A = 10 µm. Abbreviations: n, nasal; t, temporal, d, dorsal; v, ventral.
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The distribution and number of Brn3a expressing cells in the retina is not affected by Pax6 overexpression at E12.5 Figure 9
The distribution and number of Brn3a expressing cells in the retina is not affected by Pax6 overexpression at 
E12.5. (A-C) Brn3a (brown diaminobenzidine product) immunohistochemistry on coronal sections. (D-F) Brn3a immunofluo-
rescence on wholemount retina with the lens removed viewed from the front and shown as a negative greyscale image for clar-
ity. Dotted circle marks optic nerve head. (A,D) Pax6+/+, (B,E) PAX77+, (C,F) PAX77+/+. Note that in all genotypes the highest 
density of Brn3a expressing cells is located in the dorso-central retina. (G) Quantification of Brn3a positive cells showing that 
there is no significant difference in numbers in the three genotypes.Pax6+/+ n = 3, PAX77+ n = 3, PAX77+/+ n = 4. Abbreviations: 
l, lens; on, optic nerve; of, optic fissure. Dorsal is at the top in all images. Scale bars: (A-C) and (D-F) 100 µm.
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Possible causes of intraretinal RGC axonal defects
During normal development RGC axons initially grow
straight towards the optic nerve head. Overexpression of
Pax6 does not prevent RGC axons converging on the optic
nerve head altogether, but does cause a substantial pro-
portion to take a less direct route than normal. The intra-
retinal navigation defects occur before E16.5, when the
morphology of the PAX77+/+ retina is not grossly abnor-
mal, making it less likely that the distorted RGC axons are
a secondary consequence of retinal dysplasia. Intraretinal
axon navigation defects have been reported in mice lack-
ing the secreted axon guidance molecules Slit1 and/or
Slit2 [54] or the cell surface receptors EphB2 and EphB3
[55], or netrin1 and its receptor DCC (deleted in colorec-
tal cancer) [56]. Although these loss-of-function pheno-
types do not precisely phenocopy the PAX77+/+ phenotype
reported here, it is possible that Pax6 normally regulates
the expression of one or more of these molecules and that
its overexpression alters their normal balance resulting in
the intraretinal axon guidance defects we observed. As
Pax6 is expressed by RGCs themselves, and by other reti-
nal cell types, it is possible that the intraretinal pathfind-
ing errors reflect sensitivity of the RGC growth cone and/
or the environment through which it navigates to levels of
Pax6. It has recently been postulated that the lens directs
RGC axons towards the optic nerve head by secreting
repulsive Slit molecules [54]. As Pax6 plays a role in the
formation of the lens [10], and overexpressing Pax6
causes defects in lens development [57-59], it is quite pos-
sible that overexpression of Pax6 in the lens is directly
responsible for a component of the intraretinal misrout-
ing. The proper formation of the optic nerve head is also
important for intraretinal axon navigation [56] and its
altered structure in PAX77+/+  embryos could influence
axon navigation.
Possible causes of RGC axonal defects at the optic chiasm
Retinal axon navigation at the optic chiasm is controlled
by genes ranging from transcription factors [60] to cell
surface and secreted proteins [61]. Manipulating a small
subset of these genes produces specific alterations to chi-
asm organisation (for example see [53,62-66]). This com-
plex genetic control may underlie variations in the details
of chiasm construction between vertebrate species. In
mice the vast majority of retinal axons cross the ventral
midline at the optic chiasm and join the contralateral
optic tract growing towards their targets in the thalamus
and superior colliculus whereas a minority do not cross
and join the ipsilateral tract [67]. To date only a small
number of transcription factors have been identified
which control the balance between ipsilateral and contral-
ateral projections (i.e. [62,66,68,69]). A study of chick ret-
ina identified a gradient of Pax6 expression levels
consistent with a role in topographic mapping of RGC
axons via regulation of the expression of the axon guid-
ance receptor EphB2 [70]. As signalling between EphB
receptors and their ephrinB ligands have been implicated
in axon crossing behaviour at the chiasm [64], it is possi-
ble that the regulation of EphB by Pax6 is conserved
between chick and mouse and that overexpressing Pax6
alters the expression of EphB receptors on RGC growth
cones and influences their midline crossing behaviour at
the chiasm.
To investigate the relationship between Pax6 levels and
RGC axon navigation at the optic chiasm we examined an
allelic series of genotypes with different Pax6/PAX6 gene
dosage. Overexpression of Pax6 resulted in an increase in
the proportion of RGCs projecting ipsilaterally combined
with either no change in the total number projecting (as
in the PAX77+ phenotype) or with a reduction in the total
numbers projecting (as in the PAX77+/+ phenotype). Con-
versely a reduction in the total numbers projecting
occurred without changing the proportion of the ipsilat-
eral projection in the Pax6Sey/+ phenotype. This provides
strong evidence that the increased proportion of ipsilater-
ally projecting axons in PAX77+/+ embryos is not simply a
consequence of a reduced total projection. As Pax6 is
expressed by RGCs at the time their axons navigate the
midline but not by chiasm cells at the midline it is likely
Table 3: 
genotype Distribution of RGCs projecting ipsilaterally from each retinal quadrant 
(expressed as % of total projection to thalamus)
% of ipsilateral projection 
originating from vt retina
dn dt vn vt
Pax6Sey/+ 0.53 ± 0.26 0.23 ± 0.01 0.40 ± 0.20 1.44 ± 0.72 44 ± 25
Pax6+/+ 0.22 ± 0.06 0.39 ± 0.12 0.33 ± 0.17 1.16 ± 0.47 45 ± 10
PAX77+ 1.03 ± 0.46 1.59 ± 0.42 1.27 ± 0.43 4.01 ± 2.32 34 ± 11
PAX77+/+ 1.24 ± 0.71 2.30 ± 1.57 0 5.84 ± 2.70 44 ± 18
Distributions of RGCs projecting ipsialterally to the thalamus in Pax6Sey/+, Pax6+/+, PAX77+, and PAX77+/+ embryos in the four retinal quadrants. Note 
that in all genotypes the ipsilaterally projecting RGCs are enriched in the ventrotemporal (vt) quadrant (shown in bold) compared to the dorsonasal 
(dn), ventronasal (vn), and dorsotemporal (dt) quadrants regardless of the overall size of the ipsilateral projection (shown in Fig 8 B,C). All values 
mean ± s.e.m. Sample sizes: Pax6Sey/+ n = 4; Pax6+/+ n = 9; PAX77+ n = 5; PAX77+/+ n = 4.BMC Developmental Biology 2008, 8:59 http://www.biomedcentral.com/1471-213X/8/59
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that Pax6 levels in the RGCs themselves are important in
defining the navigational properties of their growth cones.
Pax6 overexpression might increase RGC axon growth
cones' sensitivity to repulsive guidance cues at the chiasm
[64], therefore reducing the proportion that will cross the
midline and project contralaterally. This might occur
either directly by regulation of axon guidance molecules,
such as EphB1 [64,70], or indirectly by regulation of tran-
scription factors, such as Zic2 [62], which program an
RGC to project ipsilaterally. In either case this is the first
evidence that Pax6 acts as an 'ipsilateral determinant' in its
own right.
Brn3a is expressed by a large population of RGCs inner-
vating the principal retinothalamic and retinocollicular
pathway [71] so is a useful marker for determining
whether the size of the population of RGCs that would
normally project to the thalamus is affected when Pax6/
PAX6 dosage is altered. RGCs projecting to ipsilateral tar-
gets in the thalamus and superior colliculus do not
express Brn3a whereas contralateral projecting RGCs do,
indicating that Brn3a expressing RGCs tend to project
contralaterally [71]. Embryos either underexpressing or
overexpressing Pax6/PAX6 have similar numbers of Brn3a
expressing RGCs but different numbers projecting to the
ipsilateral and contalateral thalamus indicating that in
our models alterations of the size of the ipsilateral or con-
tralateral projection cannot be explained by variations in
the numbers of cells expressing Brn3a. The total numbers
of Brn3a-expressing RGCs produced by Pax6Sey/+, PAX77+,
and PAX77+/+ embryos at E16.5 were very similar to one
another, although in all cases about 30% less than in
Pax6+/+ embryos. The earliest RGC projection is a transient
ipsilateral projection from the dorsocentral retina at E12.5
[72]. As Pax6 overexpression does not affect the number
or dorsocentral location of Brn3a expressing RGCs at
E12.5, it is extremely unlikely that the increased ipsilateral
projection following Pax6 overexpression is simply a con-
sequence of delayed retinal development. The 90% reduc-
tion in the total numbers of RGCs projecting to the
thalamus in Pax6Sey/+ and PAX77+/+ embryos cannot be
accounted for by a failure to generate RGCs but must be
caused by axons failing to get to the thalamus, for example
by wandering around in the retina, as seen in PAX77+/+
embryos. It is possible that some RGCs fail to project
axons out of the retina because they have a defect in
axonogenesis like that seen when RGCs lack the transcrip-
tion factor Brn3b [73].
Possible causes of early defects of optic nerve head
Pax6 is initially co-expressed with Pax2 in the early optic
stalk before becoming restricted to the optic cup by E12.5.
Baumer et al. [74] have shown that maintaining the
expression of Pax6 in the optic stalk after E12.5, by
expressing Pax6 under the control of a Pax2-upstream
promoter fragment, results in the appearance of retinal
pigmented epithelium (RPE) in the optic disc, which is
one of the earliest abnormalities detected in PAX77+/+
E14.5 embryos. Although we did not detect Pax6 in the
optic stalk of PAX77+/+ mice after E12.5, it is possible that
its overexpression causes a slight delay in its downregula-
tion in the optic stalk. Such a delay could be responsible
for the ectopic presence of RPE and retinal cells in the
optic disc.
The malformation of the optic disc in PAX77+/+ embryos
could arise as a consequence of the abnormal develop-
ment of RGC axons. Alternatively, the defects of RGC
axon guidance might be secondary to primary defects at
the optic nerve head. In this study we show that, at E16.5,
RGCs display axon guidance defects and the levels of Shh
mRNA, specifically expressed by the RGCs [40,41], are
slightly lower than normal. Previous studies have shown
that Shh, expressed by the RGCs, is implicated in retinal
lamination and RGC axon guidance. Conditional inacti-
vation of Shh in RGCs causes a complete loss of optic disc
astrocyte precursor cells, resulting in defective axon guid-
ance in the retina, as well as conversion of the neuroepi-
thelial cells in the optic stalk to pigmented cells [40]. Loss
of RGC-derived Shh also causes extensive disorganization
of the retina with the appearance of many rosettes in the
outer nuclear layer [41]. Thus, the slight decrease in Shh
expression found in the mutant retina at E16.5 could
reflect abnormalities in RGC differentiation and could
contribute to the defects in RGC axon guidance and reti-
nal lamination observed in the PAX77 retina.
In addition, another study has shown that specific abla-
tion of newly formed RGCs results in a decrease of retinal
progenitor cell proliferation and abnormally thin retinal
layers in the postnatal eye [75]. Thus, a defect in RGC dif-
ferentiation could also account for the reduced size of the
retina in PAX77+/+mice. The fact that major retinal defects
appear after RGC defects in axon guidance and Shh
expression supports the hypothesis that microphthalmia
and retinal dysplasia in PAX77+/+ eyes could be secondary
to earlier abnormalities in RGC differentiation caused by
Pax6 overexpression.
Conclusion
Higher than normal levels of Pax6 produce complex phe-
notypes in which several features of eye morphogenesis
are affected. Both increased (present study and [12]) and
decreased [76-80]Pax6 gene dosage result in defective eye
development, but the effects are quite different. Whereas
defects of Pax6+/- mice occur mainly in the anterior seg-
ment of the eye [76-80], we show here that overexpression
of Pax6 causes major defects of retinal development.
Increased Pax6 levels also affect the projection of retinal
axons. Since retinal axon navigation generally follows eyeBMC Developmental Biology 2008, 8:59 http://www.biomedcentral.com/1471-213X/8/59
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morphogenesis it is possible that a component of the
intraretinal guidance errors we detect is a secondary con-
sequence of alterations in retinal, lens, and/or optic disc
anatomy or molecular composition. The navigation errors
we detect at the chiasm are likely to reflect a requirement
for normal Pax6 levels in programming the responses of
RGCs to guidance cues at the chiasm.
Methods
Mice
PAX77 hemizygous mice [12], designated PAX77+, carry 5
to 7 copies of a 420 Kb human PAX6 YAC (Y593) with all
copies integrated at the same locus. We refer to the array
of integrated YAC Y593 copies as the PAX77 transgene.
PAX77 homozygous mice, designated PAX77+/+, carry 10
to 14 copies of human PAX6 and were genotyped by fluo-
rescent  in situ hybridization using the Fat5 probe as
described in Schedl et al. (1996) [12]. As no abnormalities
are observed in animals carrying the transgene on a
Pax6Sey/+ heterozygote background Schedl et al[12] con-
cluded that the ocular abnormalities in PAX77 mice are
due to overexpression of PAX6 and not to overexpression
of a second gene encoded by the YAC. All mice were main-
tained on an albino CD1 background. The morning of the
vaginal plug was deemed E0.5. The first 24 h after birth
was deemed P0. Animal care followed institutional guide-
lines and UK Home Office regulations.
Histology
For each stage and each genotype, at least 2 samples were
fixed in 4% paraformaldehyde : 2% glutaraldehyde, dehy-
drated to 100% ethanol and embedded in cold-polymer-
izing resin (Technovit 7100, Kulzer Histo-Technik).
Sections were cut (5 µm) and stained with cresyl violet.
Sections of whole embryos were cut horizontally and sec-
tions of postnatal eyes were cut parallel to the optic nerve.
BrdU/IdU analysis of cell-cycle parameters
The BrdU/IdU double labeling protocol is detailed in
Martynoga et al.(2005) [15]. In brief, at T = 0 h the preg-
nant mouse receives an injection of IdU which labels cells
going through S-phase from the beginning of the experi-
ment. At T = 1.5 h the female receives an injection of BrdU
and the embryos are fixed shortly after (T = 2 h). Thus, the
BrdU labels cells which are in S-phase at the end of the
experiment; this is the S fraction (Scells). The cells labeled
only by the IdU but not by the BrdU are cells which have
left S phase in the interval of 1.5 h between the two injec-
tions. This is the leaving fraction (Lcells). The cell cycle
length (Tc) and the length of S-phase (Ts) can be calcu-
lated using the equations of Shibui et al.(1989) [14]: Ts =
Ti/(Lcells/Scells) and Tc = (Scells/Pcells), where Ti is the inter-
val between the two injections and Pcells  is the total
number of proliferating cells. We made the assumption
that all progenitor cells of the retina are proliferating. The
growth fraction was not determined in this experiment.
Pregnant females were injected intra-peritoneally with
200 ml of 10 mg/ml (in 0.9% NaCl) IdU (Sigma), then
1.5 h later with the same dose of BrdU (Sigma) and they
were sacrificed after 30 min. 10 µm wax sections were
immunostained with mouse anti-BrdU/IdU (Becton
Dickinson, clone B44, 1:100) and rat anti-BrdU (Abcam,
clone BU1/75, 1:100). Cells were counted in 100 µm wide
sampling boxes in the distal and proximal retina of 3
wild-type and 3 Pax77+/+ E12.5 embryos. Each cell count
was repeated on at least 3 non-adjacent sections from each
embryo.
Immunohistochemistry
Whole embryos or postnatal eyes were fixed in 4% para-
formaldehyde and either processed to wax or cryopro-
tected in 15% and 30% sucrose and frozen.
Immunostaining for Pax6, glial fibrillary acidic protein
(GFAP), Brn3a, Islet1, bromodeoxyuridine (BrdU), Syn-
taxin and N-Cadherin (Ncad) was performed on 10 µm
paraffin sections as described in Martynoga et al. (2005)
[15]. For studies with BrdU, pregnant females were
injected intra-peritoneally with 200 µl of 10 mg/ml BrdU
(in 0.9% NaCl; Sigma) and were sacrificed after 1 hour.
Immunostaining for Chx10 and Pax2 was performed on
10 µm frozen sections as described in Martynoga et al.
(2005) [15]. R-Cadherin (Rcad) immunostaining was per-
formed on frozen sections as described in [81]. Sections of
whole embryos were cut horizontally and sections of post-
natal eyes were cut parallel to the optic nerve.
For whole-mount immunofluorescence, dissected retinae
from E16.5 embryos were incubated in blocking buffer
(20% goat serum, 0.2% Triton-X100 in phosphate buff-
ered saline [PBS]) for 20 min, followed by anti-neurofila-
ment or anti-L1 antibody overnight at 4°C. For
neurofilament detection, sections were rinsed in 0.2% Tri-
ton-X100 in PBS, and incubated with an Alexa488-conju-
gated anti-rabbit secondary (Molecular Probes, Inc). For
L1 detection, a biotinylated secondary antibody was used
with Alexa488-conjugated streptavidin (Molecular
Probes, Inc).
Primary antibodies were: Pax6 (1:400, DSHB), GFAP
(1:50, Dako), Brn3a (1:300, Chemicon; MAB1585), Islet1
(1:50, DSHB), Ncad (1:500, BD), BrdU (1:200, Becton
Dickinson), Syntaxin (1:100, Santa-Cruz sc-12736),
Chx10 (1:1000, a gift from C. Cepko), Pax2 (1:200, Cam-
bridge Bioscience), Rcad (1:100, a gift from M. Takeichi),
Neurofilament (1:100, BIOMOL, USA; NA1297), L1
(1:50, Chemicon; MAB5272).BMC Developmental Biology 2008, 8:59 http://www.biomedcentral.com/1471-213X/8/59
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Quantification of Brn3a-expressing cells in the retina
Retinae were removed from heads previously fixed in 4%
paraformaldehyde and an orientating cut made in the
ventral retina of E16.5 embryos. Retinae were boiled in 10
mM sodium citrate buffer pH6.0 for 10 minutes and
blocked in 5% goat serum, 0.2% BSA, 0.1% Triton-X1000
in PBS at room temperature before incubating overnight
at 4°C in primary antibody [Brn3a Chemicon;
MAB1585)] diluted 1:300 in blocking buffer. After wash-
ing extensively in 0.1% Triton-X1000 in PBS at room tem-
perature retinae were incubated overnight at 4°C with an
Alexa488-conjugated anti-mouse secondary (Molecular
Probes, Inc), washed extensively, and mounted with the
RGC layer uppermost in 90% glycerol containing
MOWIOL and DABCO. For E16.5 retinae, a Leica TCS NT
confocal microscope was used to acquire (1) a low power
image of the entire retina for calculation of retinal area
[see Fig 8A], (2) to scan through the entire Brn3a-express-
ing RGC layer at high power and measure its depth and
(3) to collect a series of optical sections for sampling
within the RGC layer.
Sections were 160 µm × 160 µm and were collected at
0.16 µm intervals through 8 µm of retinal depth. The
boxed area in Fig 8A shows an example of a sampling area
in ventrotemporal retina. We used a stereological
approach to calculate the density of RGCs within the sam-
pling volume: optical sections comprising the upper and
lower 4 µm of the total 8 µm stack were combined sepa-
rately to generate images like the high power inset shown
in Fig 8A. Simply counting the number of Brn3a-express-
ing nuclei in each image would give an overestimate of
nuclear density in each 160 µm × 160 µm × 4 µm volume
as nuclei protruding into the sampling volume both from
above and from below would be included in the count. To
avoid overestimating the nuclear density, we only counted
nuclei protruding into the sampling volume from one
side while excluding those that protruded from the other.
This was done by using Adobe Photoshop to pseudo-col-
our the nuclei in the upper stack red and those in the
lower stack green and then merging the two images.
Nuclei appearing yellow [red and green combined] were
present in both upper and lower stacks and so were
excluded from the count. This gave an accurate number of
Brn3a-expressing nuclei present in the sampling volume
and was used to calculate their density. For each retina the
density was calculated in the dorso-nasal and ventro-tem-
poral retina. The number of Brn3a-expressing cells in the
retina was calculated by multiplying the retinal area ×
depth of RGC layer × density of Brn3a-expressing cells in
RGC layer. For E12.5 retinae, where the density of RGCs is
much lower, a Leica TCS NT confocal microscope was
used to acquire a scan through the whole retina and total
numbers of Brn3a positive cells were counted.
Tract-Tracing
Tract-tracing was performed as described in Pratt et al.
(2006) [65]. Embryonic heads were fixed at 4°C in 4%
paraformaldehyde in PBS overnight. DiI crystals (Molecu-
lar probes, USA) were either (1) placed in the optic cup of
one eye after removal of the lens or (2) placed in a line
over the dorsal thalamus on one side to label axons navi-
gating the optic tract. Heads were returned to 4% parafor-
maldehyde in PBS in the dark at room temperature for
about six weeks to allow tracers to diffuse along axons. In
some cases the retinae were removed from the head,
cleared in 9:1 glycerol:PBS, and imaged as wholemounts
using a Zeiss Axiovert confocal LSM 510 microscope
(Zeiss, Germany). In other cases heads were sectioned
(200 µm) with a vibratome, cleared in 9:1 glycerol:PBS
containing the nuclear counterstain TOPRO3 (1.0 µM,
Molecular Probes, USA), mounted in Vectashield (Vector
Laboratories, USA), and imaged using an epifluorescence
microscope and digital camera (Leica Microsystems, Ger-
many) or a TCS NT confocal microscope (Leica Microsys-
tems, Germany). For quantification of RGC projections
the total number of DiI labelled RGCs in each retina was
counted in serial vibratome sections using an epifluores-
cence microscope as follows. Each section was viewed
under epifluorescence using a x20 objective at which mag-
nification DiI labelled RGC cell bodies are easily resolved.
An eyepiece graticule was used to divide the retina into 50
µm wide bins. Within each bin DiI labelled RGC bodies
were counted by focussing through the thickness of the
section and counting labelled cell bodies as they came
into focus. Individual bin counts were then summed to
give totals for RGCs projecting ipsilaterally and contralat-
erally to the thalamic DiI injection site in each embryo
and these totals were used to generate data presented in
Fig 7, Fig 8, and Table 3. The numbers of E16.5 embryos
used for quantification were as follows: Pax6Sey/+ n = 4;
Pax6+/+ n = 9; PAX77+ n = 5; PAX77+/+ n = 4. DiI appears
orange and TOPRO3 appears red in epifluorescence
images and in confocal images DiI appears red and
TOPRO3 appears blue.
Quantitative reverse transcription-PCR (qRT-PCR)
For each sample RNA was extracted from a pool of retinae
from a wild-type or PAX77+/+ litter using Qiagen RNeasy
kit (Qiagen, USA). cDNA synthesis was performed as
described in [82]. qRT-PCR was performed on cDNA from
E14.5 and E16.5 retinae with the following primer pairs
(n = 3 litters): Ncam (5'-GACCATCAGGAATGTGGA-3'
and 5'-AGGCTTCACAGGTCAGAGT-3'; 179 bp product);
R-cadherin  (5'-CAGTGAAACAGGGGACATC-3' and 5'-
ATACGGTTCTCAGGAACCTC-3'; 216 bp product); Ngn2
(5'-CAAACTTTCCCTCTCTGATG-3' and 5'-CATTCAAC-
CCTTACAAAAGC-3' ; 197 bp product);L1  (5'-ACCCT-
GAGGCATTACACCTG-3' and 5'-CAACTGCTCTTTGCTTT
CCC-3'; 140 bp product); Six3  (5'-CTGGAGAAC-BMC Developmental Biology 2008, 8:59 http://www.biomedcentral.com/1471-213X/8/59
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CACAAGTTCAC-3' and 5'-GATCCTGCAGGTACCACTC-
3'; 232 bp product); mouse Pax6  (5'-AACACCAACTC-
CATCAGTTC-3' and 5'-ATCTGGATAATGGGTCCTCT-3';
153 bp product); human + mouse Pax6 (5'-TAGCGAAAA
GCAACAGATG-3' and 5'-TCTATTTCTTTGCAGCTTCC-3';
250 bp product); Shh (5'-CCCTTTAGCCTACAAGCAGT-3'
and 5'-CCACTGGTTCATCACAGAG-3'; 232 bp product)
and GAPDH (5'-GGGTGTGAACCACGAGAAAT-3' and 5'-
CCTTCCACAATGCCAAAGTT-3'; 121 bp product). Quan-
titative RT-PCR was performed using Qiagen Quantitect
SYBR Green PCR Kit (Qiagen, USA) and a DNA Engine
Opticon Continuous Fluorescence Detector (GRI, UK).
The abundance of each transcript in the original RNA
sample was extrapolated from PCR reaction kinetics using
Opticon software and normalised to the level of GAPDH
transcript.
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